Browsing Bergen Open Research Archive by Author "Odsbu, Ingvild"
Now showing items 1-7 of 7
-
Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy
Cohen, Jacqueline Mallory; Alvestad, Silje; Suarez, Elizabeth A.; Schaffer, Andrea; Selmer, Randi M.; Havard, Alys; Bateman, Brian T.; Cesta, Carolyn E.; Zoega, Helga; Odsbu, Ingvild; Huybrechts, Krista F.; Kjerpeseth, Lars J.; Straub, Loreen; Leinonen, Maarit K.; Bjørk, Marte-Helene; Nørgaard, Mette; Gissler, Mika; Ulrichsen, Sinna P.; Hernandez-Diaz, Sonia; Tomson, Torbjörn; Furu, Kari (Journal article; Peer reviewed, 2023)Background and Objectives Valproate should be avoided in pregnancy, but it is the most effective drug for generalized epilepsies. Alternative treatment may require combinations of other drugs. Our objectives were to ... -
Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations
Cohen, Jacqueline Mallory; Alvestad, Silje; Cesta, Carolyn E.; Bjørk, Marte-Helene; Leinonen, Maarit; Nørgaard, Mette; Einarsdóttir, Kristjana; Engeland, Anders; Gissler, Mika; Karlstad, Øystein; Klungsøyr, Kari; Odsbu, Ingvild; Reutfors, Johan; Selmer, Randi Marie; Tomson, Torbjörn; Ulrichsen, Sinna Pilgaard; Zoega, Helga; Furu, Kari (Journal article; Peer reviewed, 2022)Objective: This study was undertaken to examine the comparative safety of antiseizure medication (ASM) monotherapy in pregnancy with respect to risk of major congenital malformations (MCMs), overall and by MCM subtype. ... -
Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; A national prospective cohort study in Norway from 2015 to 2017
Vold, Jørn Henrik; Aas, Christer Frode; Skurtveit, Svetlana; Odsbu, Ingvild; Chalabianloo, Fatemeh; Halmøy, Anne; Johansson, Kjell Arne; Fadnes, Lars T. (Journal article; Peer reviewed, 2020)Background It is estimated that up to a third of patients on opioid agonist therapy (OAT) have attention deficit hyperactivity disorder (ADHD). Treatment by ADHD medication, including a centrally acting stimulant (CAS) ... -
On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: A prospective cohort study from 2013 to 2017
Aas, Christer Frode; Vold, Jørn Henrik; Skurtveit, Svetlana; Odsbu, Ingvild; Chalabianloo, Fatemeh; Økland, Jan-Magnus; Leiva, Rafael Alexander Mo; Vickerman, Peter; Johansson, Kjell Arne; Fadnes, Lars T. (Journal article; Peer reviewed, 2020)Objectives We aimed to calculate cumulative hepatitis C virus (HCV) treatment coverage among individuals enrolled in opioid agonist therapy (OAT) in Norway between 2013 and 2017 and to document the treatment transition to ... -
Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017
Vold, Jørn Henrik; Aas, Christer Frode; Skurtveit, Svetlana; Odsbu, Ingvild; Chalabianloo, Fatemeh; Reutfors, Johan; Halmøy, Anne; Johansson, Kjell Arne; Fadnes, Lars T. (Journal article; Peer reviewed, 2020)Objectives: To compare the use of benzodiazepines, z-hypnotics, gabapentinoids, opioids and centrally acting stimulants (CAS) among patients who had received opioid agonist therapy (OAT) in Norway and Sweden during the ... -
Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countries
Dudukina, Elena; Szépligeti, Szimonetta Komjáthiné; Karlsson, Pär; Asomaning, Kofi; Daltveit, Anne Kjersti Nesje; Hakkarainen, Katja; Hoti, Fabian; Kieler, Helle; Lunde, Astrid; Odsbu, Ingvild; Rantanen, Matti; Reutfors, Johan; Saarelainen, Laura; Ehrenstein, Vera; Toft, Gunnar (Journal article; Peer reviewed, 2023)Introduction: Pregabalin is an antiepileptic drug frequently prescribed to pregnant women. Risks of adverse birth and postnatal neurodevelopmental outcomes following prenatal exposure to pregabalin are uncertain. Objective: ... -
Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017
Aas, Christer Frode; Vold, Jørn Henrik; Skurtveit, Svetlana; Odsbu, Ingvild; Chalabianloo, Fatemeh; Lim, Aaron G.; Johansson, Kjell Arne; Fadnes, Lars T. (Journal article; Peer reviewed, 2020)Background Treatment with direct-acting antiviral agents (DAAs) offers an opportunity to eliminate hepatitis C virus (HCV) endemic among people who inject drugs (PWID) and people enrolled in opioid agonist therapy (OAT) ...